Your browser doesn't support javascript.
loading
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.
Schaeffer, Eva; Kluge, Annika; Schulte, Claudia; Deuschle, Christian; Bunk, Josina; Welzel, Julius; Maetzler, Walter; Berg, Daniela.
Affiliation
  • Schaeffer E; Department of Neurology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.
  • Kluge A; Department of Neurology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.
  • Schulte C; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Deuschle C; German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany.
  • Bunk J; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Welzel J; Department of Neurology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.
  • Maetzler W; Department of Neurology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.
  • Berg D; Department of Neurology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.
J Parkinsons Dis ; 14(4): 667-679, 2024.
Article in En | MEDLINE | ID: mdl-38669557
ABSTRACT

Background:

Misfolded α-synuclein can be detected in blood samples of Parkinson's disease (PD) patients by a seed amplification assay (SAA), but the association with disease duration is not clear, yet.

Objective:

In the present study we aimed to elucidate whether seeding activity of misfolded α-synuclein derived from neuronal exosomes in blood is associated with PD diagnosis and disease duration.

Methods:

Cross-sectional samples of PD patients were analyzed and compared to samples of age- and gender-matched healthy controls using a blood-based SAA. Presence of α-synuclein seeding activity and differences in seeding parameters, including fluorescence response (in arbitrary units) at the end of the amplification assay (F60) were analyzed. Additionally, available PD samples collected longitudinally over 5-9 years were included.

Results:

In the cross-sectional dataset, 79 of 80 PD patients (mean age 69 years, SD = 8; 56% male) and none of the healthy controls (n = 20, mean age 70 years, SD = 10; 55% male) showed seeding activity (sensitivity 98.8%). When comparing subgroups divided by disease duration, longer disease duration was associated with lower α-synuclein seeding activity (F60 p < 0.001). In the longitudinal analysis 10/11 patients showed a gradual decrease of α-synuclein seeding activity over time.

Conclusions:

This study confirms the high sensitivity of the blood-based α-synuclein SAA applied here. The negative association of α-synuclein seeding activity in blood with disease duration makes this parameter potentially interesting as biomarker for future studies on the pathophysiology of disease progression in PD, and for biologically oriented trials in this field.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Alpha-Synuclein / Exosomes Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Parkinsons Dis Year: 2024 Document type: Article Affiliation country: Germany Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Alpha-Synuclein / Exosomes Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Parkinsons Dis Year: 2024 Document type: Article Affiliation country: Germany Country of publication: Netherlands